It is important to note that HDAC inhibitors have been suggested as drugs to treat cardiac diseases (McKinsey, 2012), and Vorinostat was found to improve cardiac function, for example, in models for HF with preserved ejection fraction (Wallner et al, 2018) or MI (Nagata et al, 2019). Here, HDAC9 is linked to heart disorder.